Coughlan
Chris Coughlan, Galway IE
Patent application number | Description | Published |
---|---|---|
20130036127 | DOCUMENT REGISTRY SYSTEM - A document registry system ( | 02-07-2013 |
20130041866 | Information Tracking System and Method - An information tracking system ( | 02-14-2013 |
20130041899 | Information Tracking System and Method - An information tracking system includes a plurality of sources (S | 02-14-2013 |
Christian T. Coughlan, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20140279035 | Systems and Methods for Cross-Channel Sales - This disclosure relates to methods and systems for selling products across sales channels. In one aspect the disclosure relates to receiving information regarding an item that is offered for sale by a first sales channel, receiving information regarding an item that is offered for sale by at least one second sales channel, storing the information received from the first sales channel and the at least one second sales channel, populating a product data record with the information received from the first sales channel and the at least one second sales channel, and offering, in a single transaction, items for sale from the first sales channel and the at least one second channel. | 09-18-2014 |
20140279114 | Systems and Methods for Single Swipe Cross-Channel Sales - This disclosure relates to methods and systems for selling products across sales channels in a single swipe transaction. In one aspect a method for purchasing products is disclosed. The method includes identifying a first product to be purchased from a first sales channel, determining whether the first product is available from the first sales channel, in response to determining that the first product is not available from the first sales channel, determining whether the first product is available from a second sales channel, in response to determining that the first product is available from the second sales channel, adding the first product from the second sales channel to the transaction, and selling the first product from the second sales channel, wherein the transaction is completed with a single tender. | 09-18-2014 |
Christopher Coughlan, Hudson, MA US
Patent application number | Description | Published |
---|---|---|
20100144183 | Method of mounting a connector assembly - A connector for electrical or optical conduits that provides a field configurable keying of the insulator plugs relative to each other and relative to the connector casings. A separate relative keying means is included that is separate from the case keying or locating mechanism. The connector also utilizes a retention means for example, a one-way snap apron, to retain the insulator within the receptacle case. | 06-10-2010 |
Christopher D. Coughlan, Hudson, MA US
Patent application number | Description | Published |
---|---|---|
20140206211 | COUPLING SYSTEM INCLUDING A RECEPTACLE HOUSING WITH A ROTATING DOMED DOOR - Coupling system housings including a receptacle housing with a domed protective door and a male coupler housing that may be used to actuate the receptacle housing door are disclosed. The receptacle housing may be mounted in a receiving structure. The receptacle housing is configured with a dome-shaped door that conceals and protects the connectors of an assembled receptacle when in the closed position. The receptacle housing also includes a biasing mechanism that urges the door to a closed position and maintains the door in its closed position when a male coupler is not mated to the receptacle. The male coupler housing is configured with an ergonomic handle suitable for one handed operation of the male coupler. The male coupler housing may be used to actuate the receptacle housing door during insertion and mating of and assembled male coupler to an assembled receptacle. | 07-24-2014 |
David Coughlan, Leopardstown IE
Patent application number | Description | Published |
---|---|---|
20140066507 | COSMETIC COMPOSITIONS COMPRISING EPA AND SALICYLIC ACID AND METHODS OF MAKING AND USING SAME - The present disclosure is directed generally to cosmetic compositions comprising EPA free acid and salicylic acid. In some embodiments, the cosmetic compositions have a cosmetically acceptable odor. | 03-06-2014 |
20140066509 | COSMETIC COMPOSITIONS COMPRISING EPA AND GLA AND METHODS OF MAKING AND USING SAME - The present disclosure is directed generally to cosmetic compositions comprising EPA free acid and GLA free acid. In some embodiments, the cosmetic compositions have a cosmetically acceptable odor. | 03-06-2014 |
David Coughlan, Dublin IE
Patent application number | Description | Published |
---|---|---|
20120232147 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the treatment of disease and/or disorders such as acne or atopic dermatitis. | 09-13-2012 |
20120264705 | ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing. | 10-18-2012 |
20130101533 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema. | 04-25-2013 |
20130102575 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the treatment of disease and/or disorders such as acne or atopic dermatitis. | 04-25-2013 |
20130267598 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 10-10-2013 |
20130274338 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 10-17-2013 |
20140171358 | ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA AND NEOMYCIN SULFATE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing. | 06-19-2014 |
20150093344 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema. | 04-02-2015 |
20150094370 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 04-02-2015 |
20150119593 | METHODS OF MAKING 15-HYDROXY FATTY ACID DERIVATIVES - The present disclosure provides methods of making 15-hydroxy fatty acid derivatives, such as 15-(S)-hydroxyeicosatrienoic acid (HETrE or 15-(S)-HETrE) or 15(S)-hydroxyeicosapentaenoic acid (HEPE or 15(S)-HEPE) from the corresponding fatty acid (e.g., dihomo-γ-linolenic acid (DGLA) or eicosapentaenoic acid (EPA), respectively). In some embodiments, the method comprises contacting the fatty acid with an oxidizing agent (e.g., a lipoxygenase and oxygen) in the presence of a reducing agent (e.g., cysteine) to form the 15-hydroxy fatty acid derivatives in a single reaction vessel. | 04-30-2015 |
20150152034 | Pharmaceutically Acceptable Salts of Fatty Acids - The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same. | 06-04-2015 |
David C. Coughlan, Kildare IE
Patent application number | Description | Published |
---|---|---|
20120156294 | Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration - The present invention provides pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a selective factor Xa inhibitor or a pharmaceutically acceptable salt thereof and an enhancer, wherein the enhancer is a medium chain fatty acid or a salt, ester, ether, or derivative of a medium chain fatty acid and has a carbon chain length of from 4 to 20 carbon atoms. The present invention also provides a method for obtaining a reproducible bioavailability of selective factor Xa inhibitor in a subject after oral administration comprising orally administering a pharmaceutical composition as described above. | 06-21-2012 |
20120189692 | Pharmaceutical Compositions of Iron for Oral Administration - The present invention generally relates to orally administered pharmaceutical compositions of iron compounds with medium chain fatty acid salts. The invention further relates to methods of using the pharmaceutical compositions to treat iron deficiency and related disorders. | 07-26-2012 |
David C. Coughlan, Co Kildare IE
Patent application number | Description | Published |
---|---|---|
20090280170 | Compositions of GnRH related compounds and processes of preparation - The present invention provides compositions of GnRH related compounds that are suitable for oral administration, injectable administration and other forms of administration wherein the gelling characteristics of the composition are a factor. The compositions of the present invention comprise a therapeutically effective amount of one or more GnRH related compound, and a sufficient amount of at least one anti-gelling agents to reduce the gelation of the GnRH related compound. The present invention also provides processes for preparation of a composition of one or more GnRH related compound, wherein the process comprises mixing the GnRH related compound with one or more anti-gelling agents, wherein the anti-gelling agent comprises a medium chain fatty acid salt, or an ester, an ether, or a derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms or is a surface active agent. | 11-12-2009 |
20150238561 | Compositions of GnRH related compounds and processes of preparation - The present invention provides compositions of GnRH related compounds that are suitable for oral administration, injectable administration and other forms of administration wherein the gelling characteristics of the composition are a factor. The compositions of the present invention comprise a therapeutically effective amount of one or more GnRH related compound, and a sufficient amount of at least one anti-gelling agents to reduce the gelation of the GnRH related compound. The present invention also provides processes for preparation of a composition of one or more GnRH related compound, wherein the process comprises mixing the GnRH related compound with one or more anti-gelling agents, wherein the anti-gelling agent comprises a medium chain fatty acid salt, or an ester, an ether, or a derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms or is a surface active agent. | 08-27-2015 |
David C. Coughlan, Maynooth IE
Patent application number | Description | Published |
---|---|---|
20110182985 | Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof - The present invention provides pharmaceutical compositions which are effective in providing therapeutically effective blood levels of a therapeutically active ingredient to a subject when administered to a gastrointestinal tract. In one aspect, the pharmaceutical compositions comprise a therapeutically effective amount of a therapeutically active ingredient; at least one water soluble enhancer, e.g., a medium chain fatty acid or a salt, ester, ether, or derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms; and a saccharide. | 07-28-2011 |
20110236474 | Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration - The present invention provides pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a selective factor Xa inhibitor or a pharmaceutically acceptable salt thereof and an enhancer, wherein the enhancer is a medium chain fatty acid or a salt, ester, ether, or derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms. The present invention also provides a method for obtaining a reproducible bioavailability of selective factor Xa inhibitor in an object after oral administration comprising orally administering a pharmaceutical composition as described above. | 09-29-2011 |
Guy D Coughlan, Kingsto Upon-Thames GB
Patent application number | Description | Published |
---|---|---|
20140052665 | SYSTEM AND METHOD FOR MANAGING HEDGING OF LONGEVITY RISK - A computer implemented method and system are provided for implementing a longevity bond management system for managing hedging of longevity of beneficiaries. The method may include issuing, through a special purpose vehicle, using computer processing components, a longevity bond having returns following a longevity index defined for a reference population of a pre-selected cohort of beneficiaries. The method may additionally include receiving from investors a payment amount for investment in the longevity bond, investing the payment amount in a collateral pool held by a custodian, and receiving cash flows from the investment in the collateral pool. The method may further include entering into a swap to exchange the cash flows from the investment for an amount equal to the difference between an actual and best-estimate longevity index amount and calculating, using computer processing components, based on the longevity index, a periodic payment to the investors based on the longevity performance of the pre-selected cohort of beneficiaries, such that the periodic payment increases when longevity exceeds expectations and decreases when longevity falls short of expectations. | 02-20-2014 |
Guy D. Coughlan, Surrey GB
Patent application number | Description | Published |
---|---|---|
20110029456 | System and Method for a Risk Management Framework for Hedging Mortality Risk in Portfolios Having Mortality-Based Exposure - The invention comprises a system and method for hedging or mitigating mortality exposure risk in a portfolio of mortality-dependent instruments. A mortality risk or longevity risk of the portfolio is calculated or otherwise determined. Then the sensitivity of the portfolio to mortality risk or longevity risk is calculated or otherwise determined, in other words, how much is cost or value of the portfolio affected by a change in mortality rate. To account for that mortality exposure, a selection is made of building block mortality derivatives that include age-based mortality derivatives. The selected plurality of building block mortality derivatives are used to create a hedge against the mortality risk or longevity risk of the portfolio. | 02-03-2011 |
James Francis Coughlan, Garland, TX US
Patent application number | Description | Published |
---|---|---|
20100223196 | System for Resolving Distressed Shipments - A cooperative system and an associated method are provided for resolving a distressed shipment during transport by a carrier, where the distressed shipment includes one or more parcels rendered temporarily undeliverable by an exception event while in transit from a shipper to a consignee. The inventive method involves the shipper in the task of contacting the consignee for the additional information necessary to resolve the shipment. The system creates a cooperative of participating shippers and carriers, working together to complete a shipment and thereby avoid the delay and expense associated with a premature or unnecessary return. | 09-02-2010 |
John M. Coughlan, Belfast IE
Patent application number | Description | Published |
---|---|---|
20100042739 | CONFIRMATION OF DELIVERY OF CONTENT TO AN HTTP/TCP DEVICE - A method to confirm delivery of data to a receiving device via a sending socket is disclosed. One embodiment of the method comprises determining when a predetermined amount of data has been removed from a send buffer of the sending socket and sending a confirmation when the predetermined amount of data has been removed from the send buffer. Other embodiments are described and claimed. | 02-18-2010 |
Kelley Elizabeth Coughlan, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20140235303 | Protective Carrying Apparatus For a Cellular Phone and Essential Personal Items - A protective carrying apparatus is designed to protect a cellular phone from any physical damage and to hold essential personal items such as coin or paper currency, credit or debit cards, and identification cards. The apparatus is configured to resemble a handbag or purse. The apparatus includes a formfitting phone case, a wallet, a handle, and a mirror. The formfitting phone case is used to enclose the cellular phone and has holes that allow a user to access the cellular phone's controls. The wallet is integrated onto one side of the formfitting phone case and is used to store the user's essential personal items. The mirror is mounted within the wallet but is readily available to the user. The handle is connected adjacent to the formfitting phone case so that the user can carry the apparatus and can properly orient the apparatus while operating the cellular phone. | 08-21-2014 |
Marc William Joseph Coughlan, Balmain AU
Patent application number | Description | Published |
---|---|---|
20090060170 | Method and apparatus for call control using motion and position information - A method and apparatus perform call control by obtaining initial biometric information of ears of a user of a handheld audio device; detecting a change in the biometric information of the ears of the user; determining a position and motion of the handheld audio device by analyzing the detected change in biometric information; and performing call control based on the determined position and motion. Further, the method and apparatus perform a first call control operation in response to the determined motion and position if the handheld audio device is communicating with a first endpoint and a second call control operation if communicating with a second endpoint. In addition, the method and apparatus change an internal call control operation of a handheld audio device by determining motion and a position of the handheld audio device. Also, the method and apparatus control internal operations of an endpoint by determining motion and position of the handheld audio device without terminating communication with the handheld audio device wherein the endpoint is one of a voice messaging system, conferencing system, or telephone operator. | 03-05-2009 |
20090060240 | Method and apparatus for configuring a handheld audio device using ear biometrics - A method and apparatus configure a handheld audio device to communicate audio information by identifying an ear being used with the handheld audio device and by configuring the handheld audio device in response to the ear identification to communicate audio information to the ear. The identification may use sonic or visual techniques to identify the ear. | 03-05-2009 |
20090061819 | Method and apparatus for controlling access and presence information using ear biometrics - A method and apparatus control the operations of an audio device by obtaining by the audio device biometric information about an ear of a user; identifying the user by processing the biometric information; and controlling the operation of the audio device in response to the identification of the user. Also, a method and apparatus control the operations of an external database by receiving biometric information about the ear of a user from an audio device; identifying the user by processing the biometric information; and transmitting a control message to another system. Further, a method and apparatus control the operations of a telecommunication system by receiving biometric information about an ear of a user from a telecommunication set; identifying the user by processing the biometric information; and controlling the operation of the telecommunication system in response to the identification of the user. | 03-05-2009 |
Michael Coughlan, Leixlip IE
Patent application number | Description | Published |
---|---|---|
20080313294 | MESSAGING SYSTEM - A messaging system comprises a server which registers clients (users) and stores uploaded contact data in contacts databases. The contact databases have meta data including profile attributes indicating the subject matter profiles of the contacts. A content manager receives content items such as collateral parts and message text and stores them in content databases, also with meta data having profile attributes. When a client requests a message to be sent to a contact, the content manager automatically identifies relevant content items according to the profile attributes, and a messaging engine sends a message with a wrapper having links to these content items. When the contact responds, a response management function captures response data and instructs a build engine to build content from the identified items. The content is then sent to the contact. | 12-18-2008 |
Sean Coughlan, Dublin IE
Patent application number | Description | Published |
---|---|---|
20100064377 | ACCESS RIGHTS FOR DIGITAL OBJECTS - A digital object for distribution from a provider to a content user and a method of distribution of such an object is disclosed. The digital object comprises content and a tag containing data that is derived algorithmically from the content and from a secret not known to the content user. The tag is constructed such that the content user can, upon receipt of a communication from a requestor purporting to have the authority of the provider, perform an exchange of information with the requestor, and by inspection of the exchanged information and of the tag, determine whether the requestor is in possession of the secret and choose to act upon or not act upon the communication accordingly. The tag may additionally include a value that defines an access category that specifies the extent to which the owner wishes the content to be distributed. A server from which an object has been delivered to a third party can send a message to the third party to request, amongst other things, that the access category be changed. The third party can use the tag in the object to verify the authority of the request. | 03-11-2010 |
20110004924 | CHALLENGE-RESPONSE SYSTEM AND METHOD - A content-based authorisation method is described, wherein the method is operable to validate that a user has access to certain content. By having access to the content, the system is able to decide that the user is authorised to access the content, and may perform operations or set access rights accordingly. | 01-06-2011 |
Sean J. Coughlan, Hockessin, DE US
Patent application number | Description | Published |
---|---|---|
20100275324 | Compositions and Methods for Altering Tocotrienol Content - The invention provides isolated nucleic acids and their encoded polypeptides that alter tocol content in seeds. The invention further provides expression cassettes, host cells and transformed plants containing the nucleic acids. The present invention further provides methods for altering tocol content in seeds. | 10-28-2010 |
20120272407 | COMPOSITIONS AND METHODS FOR ALTERING TOCOTRIENOL CONTENT - The invention provides isolated nucleic acids and their encoded polypeptides that alter tocol content in seeds. The invention further provides expression cassettes, host cells and transformed plants containing the nucleic acids. The present invention further provides methods for altering tocol content in seeds. | 10-25-2012 |
20130316457 | Compositions and Methods for Altering Tocotrienol Content - The invention provides isolated nucleic acids and their encoded polypeptides that alter tocol content in seeds. The invention further provides expression cassettes, host cells and transformed plants containing the nucleic acids. The present invention further provides methods for altering tocol content in seeds. | 11-28-2013 |
William Coughlan, Myrtle Beach, SC US
Patent application number | Description | Published |
---|---|---|
20150266138 | Nickel-Iron-Phosphorus Brazing Alloys - Disclosed is a semi-amorphous, ductile brazing foil with a composition consisting essentially of Ni | 09-24-2015 |
20150266139 | Nickel-Iron-Phosphorus Brazing Alloys - Disclosed is a semi-amorphous, ductile brazing foil with a composition consisting essentially of Ni | 09-24-2015 |